SGLT2 Inhibitors May Slow the Growth of Early Lung Cancer
SGLT2 inhibitors, a class of FDA-approved anti-diabetes medications, may slow the progression of in situ pulmonary adenocarcinoma and reduce the need for surgical interventions,...
Gender Disparities in Farmer’s Lung Disease Treatment
Although males and females with farmer’s lung disease have comparable odds of developing acute respiratory failure, a new study reports that females may have...
Steroid-Sparing Agents Show Promise in Stabilizing Lung Function in Hypersensitivity Pneumonitis
Patients with hypersensitivity pneumonitis who were treated with mycophenolate mofetil or azathioprine for 12 months showed stable forced vital capacity (FVC) with no significant...
Private Equity Hospital Acquisitions Linked to Worse Outcomes for Pulmonary Patients
Private equity hospital acquisitions in the United States worsen the quality of care for patients with asthma, COPD, or pneumonia. After being acquired by...